... Jan 28
... Dec 22
The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
Odisha has consistently been witnessing a declining trend in COVID-19 cases... Oct 16
Now Indoco joins Favipiravir production with 400mg tablets... Sep 28
The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ... Sep 26
Russia pushes the cheapest covid drug Avifavir... Sep 25
Completed phase 3 clinical study paves way for approval request... Sep 24
Coronavir's approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avifavir, in May... Sep 19
After 200 mg favipiravir tablets BDR to launch 400 mg Favipiravir tablets under brand name BDFAVI... Sep 07
Brinton Pharma makes Covid treatment manageable by launching 400 mg tablets at Rs 79... Aug 21
Favipiravir licensed from Fujifilm by Dr Reddy's ... Aug 20
Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name ... Aug 18
Sun Pharma testing pancreatitis drug to battle Covid-19 ... Aug 13
Cipla's launch of remdesivir in late June, along with subsequent launches by others, has helped ease supply bottlenecks in India... Aug 12
Glenmark the first company to launch Favipiravir in India now launches 400 mg tablets... Aug 06
Now Lupin also launches Favipiravir for mild to moderate Covid infection... Aug 05
Converge Biotech, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for ... Aug 04
Sun Pharma launches cheapest Favipiravir at Rs 35... Aug 04
Hetero announces today the launch of generic Favipiravir in India under the brand name ‘Favivir... Jul 29
Hyderabad's Avra Labs to make Favipiravir for Cipla's Ciplenza ... Jul 28
Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19... Jul 27
Latest on Covid developments across the states as on July 26 ... Jul 26
Favivent is manufactured at a pharmaceutical plant which is compliant with US-FDA and EDQM standards... Jul 25
-Advertisements-
Friday, May 03, 2024
.jpeg)
